VRTX

Vertex Pharmaceuticals Incorporated News Headlines

$64.17
*  
0.22
 negative 
0.34%
Get VRTX Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

CHMP Positive on Vertex's Kalydeco - Analyst Blog
5/29/2012 9:44:31 AM - Zacks.com

Pre-Market Most Active for May 29, 2012 : VRTX, BAC, NOK, LCRY, FB, GNOM, STD, BHP, GRFS, AMRN, BUD, C
5/29/2012 8:39:59 AM - NASDAQ.com News

Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN
5/14/2012 11:07:42 AM - GuruFocus

Vertex Pharma's CF Drug Outperforms - Analyst Blog
5/8/2012 5:59:01 PM - Zacks.com

Dow Endures a 198-Point Collapse as Greece Takes the Reins
5/8/2012 4:27:01 PM - Schaeffer's Investment Research

Dow Endures a 198-Point Collapse as Greece Takes the Reins
5/8/2012 4:27:01 PM - Schaeffer's Investment Research

Western Markets Shake Off Euro Election Jitters: Daily Markets Wrap.
5/7/2012 4:18:54 PM - International Business Times

Pre-Market Most Active for May 7, 2012 : AIG, HMC, VRTX, T, NYB, BAC, DPZ, SIRI, ERIC, QQQ, ZNGA, AAPL
5/7/2012 8:39:55 AM - NASDAQ.com News

Merck Beats by a Penny; Affirms View - Analyst Blog
4/27/2012 10:45:01 AM - Zacks.com

Vertex Reports Positive Data on Incivek - Analyst Blog
4/20/2012 1:45:01 PM - Zacks.com

Vertex' HCV-HIV Treatment Impresses - Analyst Blog
3/21/2012 1:22:35 PM - Zacks.com

4 Potential Takeover Targets In Biotechnology And Drugs Industry
3/13/2012 3:36:00 PM - Seeking Alpha

Addressing Vertex / Gilead Confusion
3/1/2012 2:02:00 PM - Seeking Alpha

Recent FDA Approval Makes Vertex A Ripe Target For Takeover
3/1/2012 11:21:00 AM - Seeking Alpha

Positive Data on VRTX Combo Therapy - Analyst Blog
2/29/2012 7:38:01 PM - Zacks.com

Hepatitis C Remains A Hot Play
2/27/2012 4:06:00 AM - Seeking Alpha

Recent Performance Review For 7 Biotech Equities
2/24/2012 10:57:00 AM - Seeking Alpha

4 Compelling Alternatives To Vertex Pharma
2/23/2012 8:21:00 AM - Seeking Alpha

Vertex: The Best Of The Companies Investing In Cystic Fibrosis
2/21/2012 9:34:00 AM - Seeking Alpha

Friday's Overreaction Provides Great Entry Point For Gilead
2/21/2012 4:11:00 AM - Seeking Alpha

3 Killer Criteria for Super Swing Trades - Weekend Wisdom
2/17/2012 4:33:01 PM - Zacks.com

Gilead's Electron Data Brings Some Reality Back To The Hep C Market
2/17/2012 9:03:00 AM - Seeking Alpha

Label Update for Merck's Victrelis - Analyst Blog
2/13/2012 4:15:01 PM - Zacks.com

Illumina, Roche And Fairness
2/9/2012 5:37:00 PM - Seeking Alpha

Analyzing Tuesday's Noteworthy Insider Buys And Sells In Healthcare And Technology
2/8/2012 7:08:00 PM - Seeking Alpha